Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1983 2
1985 1
1986 3
1987 4
1988 4
1989 1
1994 1
1997 1
1999 2
2001 3
2002 1
2003 5
2004 2
2005 1
2007 1
2009 3
2011 1
2012 1
2015 2
2016 3
2017 1
2018 1
2020 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).
Cardoso F, Paluch-Shimon S, Senkus E, Curigliano G, Aapro MS, André F, Barrios CH, Bergh J, Bhattacharyya GS, Biganzoli L, Boyle F, Cardoso MJ, Carey LA, Cortés J, El Saghir NS, Elzayat M, Eniu A, Fallowfield L, Francis PA, Gelmon K, Gligorov J, Haidinger R, Harbeck N, Hu X, Kaufman B, Kaur R, Kiely BE, Kim SB, Lin NU, Mertz SA, Neciosup S, Offersen BV, Ohno S, Pagani O, Prat A, Penault-Llorca F, Rugo HS, Sledge GW, Thomssen C, Vorobiof DA, Wiseman T, Xu B, Norton L, Costa A, Winer EP. Cardoso F, et al. Among authors: vorobiof da. Ann Oncol. 2020 Dec;31(12):1623-1649. doi: 10.1016/j.annonc.2020.09.010. Epub 2020 Sep 23. Ann Oncol. 2020. PMID: 32979513 Free PMC article. No abstract available.
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.
Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, Harbeck N, Aguilar Lopez B, Barrios CH, Bergh J, Biganzoli L, Boers-Doets CB, Cardoso MJ, Carey LA, Cortés J, Curigliano G, Diéras V, El Saghir NS, Eniu A, Fallowfield L, Francis PA, Gelmon K, Johnston SRD, Kaufman B, Koppikar S, Krop IE, Mayer M, Nakigudde G, Offersen BV, Ohno S, Pagani O, Paluch-Shimon S, Penault-Llorca F, Prat A, Rugo HS, Sledge GW, Spence D, Thomssen C, Vorobiof DA, Xu B, Norton L, Winer EP. Cardoso F, et al. Among authors: vorobiof da. Ann Oncol. 2018 Aug 1;29(8):1634-1657. doi: 10.1093/annonc/mdy192. Ann Oncol. 2018. PMID: 30032243 Free PMC article. No abstract available.
Breast cancer incidence in South Africa.
Vorobiof DA, Sitas F, Vorobiof G. Vorobiof DA, et al. J Clin Oncol. 2001 Sep 15;19(18 Suppl):125S-127S. J Clin Oncol. 2001. PMID: 11560987 Review.
Asbestos and mesothelioma in South Africa.
Abratt RP, Vorobiof DA, White N. Abratt RP, et al. Among authors: vorobiof da. Lung Cancer. 2004 Aug;45 Suppl 1:S3-6. doi: 10.1016/j.lungcan.2004.04.007. Lung Cancer. 2004. PMID: 15261425 Review.
Primary osteosarcoma of the breast: a case report.
Vorobiof G, Hariparsad G, Freinkel W, Said H, Vorobiof DA. Vorobiof G, et al. Among authors: vorobiof da. Breast J. 2003 May-Jun;9(3):231-3. doi: 10.1046/j.1524-4741.2003.09320.x. Breast J. 2003. PMID: 12752633 Review.
The cancer burden in Africa.
Vorobiof DA, Abratt R. Vorobiof DA, et al. S Afr Med J. 2007 Oct;97(10):937, 939. S Afr Med J. 2007. PMID: 18000571 No abstract available.
Bone targeted therapies in early breast cancer.
Tabane K, Vorobiof DA. Tabane K, et al. Among authors: vorobiof da. Curr Treat Options Oncol. 2011 Dec;12(4):412-23. doi: 10.1007/s11864-011-0163-3. Curr Treat Options Oncol. 2011. PMID: 21887503
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.
Moccia AA, Taverna C, Schär S, Vanazzi A, Rondeau S, Hitz F, Mingrone W, Pabst T, Cevreska L, Del Giglio A, Raats J, Rauch D, Vorobiof DA, Lohri A, Ruegsegger C, Biaggi Rudolf C, Rusterholz C, Hayoz S, Ghielmini M, Zucca E. Moccia AA, et al. Among authors: vorobiof da. Blood Adv. 2020 Dec 8;4(23):5951-5957. doi: 10.1182/bloodadvances.2020002858. Blood Adv. 2020. PMID: 33275769 Free PMC article. Clinical Trial.
47 results